Dr. Kenichiro Hasumi is a physician, specialized in cancer immunotherapy and terminal care. He is also a researcher and visionary, focused on the development of cancer vaccines and improved clinical treatments to achieve better patient outcomes with a higher quality of life.
Dr. Hasumi is also responsible for immunotherapy by use of the Hasumi vaccine. The Hasumi vaccine has been used by over 100,000 cancer patients during the past fifty years in more than twenty countries, without the occurrence of any severe side effects. Dr. Hasumi intends to devote all of his abilities and his experience to direct and manage the Hasumi Foundation for the benefit of human kind.
Dr. Hasumi also is chairman of Shukokai Clinic, Hijirigaoka Hospital, Hijiri-no-Sato Elderly Health Care Facility, and The Electro-Chemical and Cancer Institute; all these institutions are located in Tokyo, Japan. He was also the primary organizer and founder for the World Immuno-Society for Health (WISH), a nonprofit organization helping physicians, patients and their families become more aware and understanding of cancer treatment and care through networking.